UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Breast cancer in China

The lancet oncology, 2014-06, Vol.15 (7), p.e279-e289

2014

Volltextzugriff (PDF)

Prediction of late distant recurrence in patients with oestrogen-receptor-positive breast cancer: a prospective comparison of the breast-cancer index (BCI) assay, 21-gene recurrence score, and IHC4 in the TransATAC study population

The lancet oncology, 2013-10, Vol.14 (11), p.1067-1076

2013

Volltextzugriff (PDF)

Longer-Term Outcomes of Letrozole Versus Placebo After 5 Years of Tamoxifen in the NCIC CTG MA.17 Trial: Analyses Adjusting for Treatment Crossover

Journal of clinical oncology, 2012-03, Vol.30 (7), p.718-721

2012

Volltextzugriff (PDF)

Postpartum breast cancer has a distinct molecular profile that predicts poor outcomes

Nature communications, 2021-11, Vol.12 (1), p.6341-6341, Article 6341

2021

Volltextzugriff (PDF)

Prediction of Late Disease Recurrence and Extended Adjuvant Letrozole Benefit by the HOXB13/IL17BR Biomarker

JNCI : Journal of the National Cancer Institute, 2013-07, Vol.105 (14), p.1036-1042

2013

Volltextzugriff (PDF)

Epidemiology and pathophysiology of pregnancy-associated breast cancer: A review

Breast (Edinburgh), 2017-10, Vol.35, p.136-141

2017

Volltextzugriff (PDF)

Exemestane Versus Anastrozole in Postmenopausal Women With Early Breast Cancer: NCIC CTG MA.27—A Randomized Controlled Phase III Trial

Journal of clinical oncology, 2013-04, Vol.31 (11), p.1398-1404

2013

Volltextzugriff (PDF)

Lapatinib: Current Status and Future Directions in Breast Cancer

The oncologist (Dayton, Ohio), 2006-11, Vol.11 (10), p.1047-1057

2006

Volltextzugriff (PDF)

The Emerging Role of the Insulin‐Like Growth Factor Pathway as a Therapeutic Target in Cancer

The oncologist (Dayton, Ohio), 2008-01, Vol.13 (1), p.16-24

2008

Volltextzugriff (PDF)

Breast cancer in Mexico: a growing challenge to health and the health system

The lancet oncology, 2012-08, Vol.13 (8), p.e335-e343

2012

Volltextzugriff (PDF)

Randomized Trial of Letrozole Following Tamoxifen as Extended Adjuvant Therapy in Receptor-Positive Breast Cancer: Updated Findings from NCIC CTG MA.17

JNCI : Journal of the National Cancer Institute, 2005-09, Vol.97 (17), p.1262-1271

2005

Volltextzugriff (PDF)

Breast cancer in Brazil: present status and future goals

The lancet oncology, 2012-03, Vol.13 (3), p.e95-e102

2012

Volltextzugriff (PDF)

A Randomized Trial of Letrozole in Postmenopausal Women after Five Years of Tamoxifen Therapy for Early-Stage Breast Cancer

The New England journal of medicine, 2003-11, Vol.349 (19), p.1793-1802

2003

Volltextzugriff (PDF)

Genetic Polymorphisms in the Long Noncoding RNA MIR2052HG Offer a Pharmacogenomic Basis for the Response of Breast Cancer Patients to Aromatase Inhibitor Therapy

Cancer research (Chicago, Ill.), 2016-12, Vol.76 (23), p.7012-7023

2016

Volltextzugriff (PDF)

Genome-Wide Associations and Functional Genomic Studies of Musculoskeletal Adverse Events in Women Receiving Aromatase Inhibitors

Journal of clinical oncology, 2010-11, Vol.28 (31), p.4674-4682

2010

Volltextzugriff (PDF)

Aromatase Inhibitors in the Treatment and Prevention of Breast Cancer

Journal of clinical oncology, 2001-02, Vol.19 (3), p.881-894

2001

Volltextzugriff (PDF)

Effect of Letrozole Versus Placebo on Bone Mineral Density in Women With Primary Breast Cancer Completing 5 or More Years of Adjuvant Tamoxifen: A Companion Study to NCIC CTG MA.17

Journal of clinical oncology, 2006-08, Vol.24 (22), p.3629-3635

2006

Volltextzugriff (PDF)

Late Extended Adjuvant Treatment With Letrozole Improves Outcome in Women With Early-Stage Breast Cancer Who Complete 5 Years of Tamoxifen

Journal of clinical oncology, 2008-04, Vol.26 (12), p.1948-1955

2008

Volltextzugriff (PDF)

Aromatase Inhibitor-Associated Bone Fractures: A Case-Cohort GWAS and Functional Genomics

Molecular endocrinology (Baltimore, Md.), 2014-10, Vol.28 (10), p.1740-1751

2014

Volltextzugriff (PDF)

Estrogen, SNP-Dependent Chemokine Expression and Selective Estrogen Receptor Modulator Regulation

Molecular endocrinology (Baltimore, Md.), 2016-03, Vol.30 (3), p.382-398

2016

Volltextzugriff (PDF)

Cognitive Function, Fatigue, and Menopausal Symptoms in Women Receiving Adjuvant Chemotherapy for Breast Cancer

Journal of clinical oncology, 2003-11, Vol.21 (22), p.4175-4183

2003

Volltextzugriff (PDF)

Randomized Trial of Tamoxifen Versus Combined Tamoxifen and Octreotide LAR Therapy in the Adjuvant Treatment of Early-Stage Breast Cancer in Postmenopausal Women: NCIC CTG MA.14

Journal of clinical oncology, 2011-10, Vol.29 (29), p.3869-3876

2011

Volltextzugriff (PDF)

Dietary Flaxseed Alters Tumor Biological Markers in Postmenopausal Breast Cancer

Clinical cancer research, 2005-05, Vol.11 (10), p.3828-3835

2005

Volltextzugriff (PDF)

1 – 25 von 370

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(352)
Mit Volltextzugriff
(330)

Publikationsform

Artikel
(364)
Buchkapitel
(4)
Reviews
(1)
Texte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(243)
Life Sciences & Biomedicine
(238)
Humans
(229)
Female
(181)
Oncology
(167)
Biological And Medical Sciences
(103)
Breast Neoplasms - Drug Therapy
(97)
Medical Sciences
(96)
Middle Aged
(96)
Aged
(82)
Breast Cancer
(76)
Adult
(64)
Tumors
(58)
Breast Neoplasms - Pathology
(51)
Male
(47)
Chemotherapy, Adjuvant
(44)
Postmenopause
(41)
Treatment Outcome
(41)
Pharmacology. Drug Treatments
(40)
Aromatase Inhibitors - Therapeutic Use
(38)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Breast cancer in China

Prediction of late distant recurrence in patients with oestrogen-receptor-positive breast cancer: a prospective comparison of the breast-cancer index (BCI) assay, 21-gene recurrence score, and IHC4 in the TransATAC study population

Longer-Term Outcomes of Letrozole Versus Placebo After 5 Years of Tamoxifen in the NCIC CTG MA.17 Trial: Analyses Adjusting for Treatment Crossover

Postpartum breast cancer has a distinct molecular profile that predicts poor outcomes

Prediction of Late Disease Recurrence and Extended Adjuvant Letrozole Benefit by the HOXB13/IL17BR Biomarker

Epidemiology and pathophysiology of pregnancy-associated breast cancer: A review

Exemestane Versus Anastrozole in Postmenopausal Women With Early Breast Cancer: NCIC CTG MA.27—A Randomized Controlled Phase III Trial

Lapatinib: Current Status and Future Directions in Breast Cancer

The Emerging Role of the Insulin‐Like Growth Factor Pathway as a Therapeutic Target in Cancer

Breast cancer in Mexico: a growing challenge to health and the health system

Randomized Trial of Letrozole Following Tamoxifen as Extended Adjuvant Therapy in Receptor-Positive Breast Cancer: Updated Findings from NCIC CTG MA.17

Breast cancer in Brazil: present status and future goals

Adjuvant lapatinib for women with early-stage HER2-positive breast cancer: a randomised, controlled, phase 3 trial

A Randomized Trial of Letrozole in Postmenopausal Women after Five Years of Tamoxifen Therapy for Early-Stage Breast Cancer

Genetic Polymorphisms in the Long Noncoding RNA MIR2052HG Offer a Pharmacogenomic Basis for the Response of Breast Cancer Patients to Aromatase Inhibitor Therapy

Genome-Wide Associations and Functional Genomic Studies of Musculoskeletal Adverse Events in Women Receiving Aromatase Inhibitors

Aromatase Inhibitors in the Treatment and Prevention of Breast Cancer

Effect of Letrozole Versus Placebo on Bone Mineral Density in Women With Primary Breast Cancer Completing 5 or More Years of Adjuvant Tamoxifen: A Companion Study to NCIC CTG MA.17

Late Extended Adjuvant Treatment With Letrozole Improves Outcome in Women With Early-Stage Breast Cancer Who Complete 5 Years of Tamoxifen

Aromatase Inhibitor-Associated Bone Fractures: A Case-Cohort GWAS and Functional Genomics

Estrogen, SNP-Dependent Chemokine Expression and Selective Estrogen Receptor Modulator Regulation

Bone density and structure in healthy postmenopausal women treated with exemestane for the primary prevention of breast cancer: a nested substudy of the MAP.3 randomised controlled trial

Cognitive Function, Fatigue, and Menopausal Symptoms in Women Receiving Adjuvant Chemotherapy for Breast Cancer

Randomized Trial of Tamoxifen Versus Combined Tamoxifen and Octreotide LAR Therapy in the Adjuvant Treatment of Early-Stage Breast Cancer in Postmenopausal Women: NCIC CTG MA.14

Dietary Flaxseed Alters Tumor Biological Markers in Postmenopausal Breast Cancer

Suchergebnisse filtern